Related Experiment Video
Updated: Dec 30, 2025

11:15
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.6K
Exosomes in Bone Sarcomas: Key Players in Metastasis
Mariona Chicón-Bosch1, Oscar M Tirado1,2,3
1Sarcoma Research Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Cells
|January 23, 2020
Summary
Exosomes, tiny vesicles involved in cell communication, are key drivers of bone sarcoma progression and metastasis. Understanding their role is crucial for improving treatment outcomes in these rare cancers.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Bone sarcomas are rare, aggressive cancers with high metastatic rates and poor prognoses.
- Exosomes, extracellular vesicles, mediate intercellular communication and influence tumor progression.
- Exosomes play roles in metastasis, angiogenesis, and cell-cell interactions within the tumor microenvironment.
Purpose of the Study:
- To review the current understanding of exosome involvement in bone sarcoma development and metastasis.
- To highlight the significance of exosomes in osteosarcoma, Ewing sarcoma, and chondrosarcoma.
Main Methods:
- Literature review of studies investigating exosomes in bone sarcomas.
- Analysis of research on exosome cargo (RNAs, proteins, lipids) and their functional impact.
- Synthesis of findings related to exosome-mediated cellular cross-talk and phenotypic changes.
Main Results:
- Exosomes contribute to metastasis organotropism and angiogenesis in bone sarcomas.
- Tumor-derived exosomes can educate recipient cells, promoting a pro-metastatic environment.
- Exosomes facilitate interactions between stromal and tumor cells, influencing disease progression.
Conclusions:
- Exosomes are critical mediators of bone sarcoma progression and metastasis.
- Further research into exosome function in bone sarcomas may reveal novel therapeutic targets.
- Targeting exosome pathways holds promise for improving outcomes in patients with bone sarcomas.
Related Concept Videos
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

